In patients undergoing laparoscopic sleeve gastrectomy, 22.2% of those with prior liraglutide use had stomach-pancreas adhesions, and none of the controls without prior liraglutide had adhesions.
In plain wordsIn people having sleeve gastrectomy, adhesions were found in 22.2% of those who had used liraglutide and in none of those who had not.
- Peptide
- Liraglutide
- Outcome
- IncreaseAdhesions between posterior stomach and pancreas at sleeve gastrectomy
- Study
n = 218
- Comparator
- No prior liraglutide use
- Outcome group
- Adverse events · Gastrointestinal
- Studied dose
- Dose not stated
Measurements
- Incidence of adhesions
- 22.2%
- prior liraglutide use
Source sentences
Under the cases group, 77.8% of the patients had no adhesions, while 22.2% had adhesions. Under the controls group, no adhesions were seen (p < 0.001).
1 context sentence(design, population, supporting numbers)
117 patients with prior use of liraglutide and 101 patients with no liraglutide use scheduled for LSG over 12 months were included.